Developed by Shray Alag, The Harker School
Sections: Correlations,
Clinical Trials, and HPO
Navigate: Clinical Trials and HPO
| Name (Synonyms) | Correlation |
|---|
Navigate: Correlations HPO
There is one clinical trial.
This study seeks to determine how COVID-19 affects the clinical outcome of patients with chronic liver disease, and whether the clinical course of COVID-19 is influenced by underlying chronic liver disease.
Description: Death due to any cause
Measure: All-cause mortality Time: 30 daysDescription: Death due to any cause
Measure: All-cause mortality Time: 1 yearDescription: Death due to liver-related cause
Measure: Liver-related mortality Time: 28 daysDescription: Death due to liver-related cause
Measure: Liver-related mortality Time: 1 yearDescription: Patients will be assessed for this outcome for up to 1 year
Measure: Overall survival Time: Up to 1 yearDescription: Onset of hepatic decompensation due to COVID-19 disease; patients will be assessed for this outcome for up to 1 year
Measure: Number of patients with hepatic decompensation Time: Up to 1 yearDescription: Patients will be assessed for this outcome for up to 1 year.
Measure: Number of patients requiring hospitalization Time: Up to 1 yearDescription: Patients will be assessed for this outcome for up to 1 year.
Measure: Duration of hospitalization Time: Up to 1 yearDescription: Patients will be assessed for this outcome for up to 1 year.
Measure: Length of intensive care unit (ICU) stay Time: Up to 1 yearDescription: Patients will be assessed for this outcome for up to 1 year.
Measure: Number of participants requiring mechanical ventilation Time: Up to 1 yearAlphabetical listing of all HPO terms. Navigate: Correlations Clinical Trials
Data processed on September 26, 2020.
An HTML report was created for each of the unique drugs, MeSH, and HPO terms associated with COVID-19 clinical trials. Each report contains a list of either the drug, the MeSH terms, or the HPO terms. All of the terms in a category are displayed on the left-hand side of the report to enable easy navigation, and the reports contain a list of correlated drugs, MeSH, and HPO terms. Further, all reports contain the details of the clinical trials in which the term is referenced. Every clinical trial report shows the mapped HPO and MeSH terms, which are also hyperlinked. Related HPO terms, with their associated genes, protein mutations, and SNPs are also referenced in the report.
Drug Reports MeSH Reports HPO Reports